StockData
Spero Therapeutics, Inc. logo

Spero Therapeutics, Inc. (SPRO) stock

SPRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3041% below fair value
$1.00−0.02 (-1.96%)

Close on Nov 12, 2026Market cap $58.23MP/E –Yield –

Spero Therapeutics statistics

70 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Nov 12, 2026 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$58.23M
$280.48M
Enterprise Value
-$49.69M
$148.62M
PS Ratio
1.40
3.60
PB Ratio
74.56
2.05
P/TBV Ratio
74.56
2.29

Enterprise valuationIndustry

EV / Sales
-1.20
2.60

Share statisticsIndustry

Shares Change (YoY)
8.91%
10.9%
Shares Change (QoQ)
0.16%
0.48%
Float
44M
49M
Shares Held by Insiders
24.6%
12.1%
Shares Held by Institutions
36.9%
56.4%

Short sellingIndustry

Short Interest
787,025
–
Short Interest Change
-6.37%
-0.76%
Short % of Float
1.79%
9.06%
Short % of Shares Outstanding
1.35%
6.30%
Days to Cover
2.23
5.13

Stock price statisticsIndustry

52-Week High
$3.08
–
52-Week Low
$0.96
–
20-Day Moving Average
$1.08
–
50-Day Moving Average
$1.14
–
200-Day Moving Average
$1.92
–
Average True Range (14)
$0.06
–
Price Change (1 Week)
-1.96%
1.51%
Price Change (1 Month)
-10.7%
-2.37%
Price Change (3 Months)
-18.7%
-21.1%
Price Change (6 Months)
-63.8%
-22.8%
Price Change (YTD)
-57.1%
-22.6%
Price Change (1 Year)
-61.8%
-21.0%
Price Change (3 Years)
-9.91%
-24.8%
Price Change (5 Years)
-94.0%
-76.9%
Average Volume (10 Days)
312,264
–
Average Volume (20 Days)
336,103
–
Average Volume (90 Days)
957,372
–
Relative Volume
0.34
0.80
Relative Strength Index (14)
39.4
44.7
Volatility (1 Year)
64.1%
80.2%
Beta (5 Years)
1.13
1.07

MarginsIndustry

Operating Margin
-67.3%
-38.5%
Profit Margin
-71.0%
-31.7%
EBITDA Margin
-67.3%
-27.7%

Returns on capitalIndustry

Return on Equity (ROE)
-216.4%
-51.3%
Return on Assets (ROA)
-35.9%
-40.7%
Return on Capital Employed (ROCE)
-52.7%
-38.1%

Financial positionIndustry

Current Ratio
1.92
3.31
Quick Ratio
1.89
2.41

GrowthIndustry

Revenue Growth (YoY)
2.48%
7.26%
Revenue Growth (3Y CAGR)
7.68%
2.25%
Revenue Growth (5Y CAGR)
48.2%
6.41%

EfficiencyIndustry

Asset Turnover
0.51
0.40
Revenue Per Employee
$1.66M
$429.38K
Profits Per Employee
-$1.18M
-$683.67K
Employee Count
25
75
WACC
10.5%
10.0%

Income statement (TTM)Industry

Revenue
$41.56M
$66.69M
Operating Income
-$27.97M
-$20.99M
Net Income
-$29.51M
-$21.61M
EBITDA
-$27.97M
-$16.85M
EPS (Diluted)
-$0.59
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$107.93M
$16.98M
Net Cash Per Share
$1.85
$0.72
Equity (Book Value)
$781.00K
$52.68M
Book Value Per Share
$0.01
$1.50
Tangible Book Value
$781.00K
$26.74M
Working Capital
$52.27M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$40.45M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-50.7%
-21.0%

Scores and fair valueIndustry

Altman Z-Score
-6.09
0.26
Piotroski F-Score
5
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodSPROS&P 500DifferenceSPRO per yearS&P 500 per year
1 month-15.3%-2.7%−12.6 pts
3 months-16.0%-1.7%−14.2 pts
Year to date-57.1%+11.9%−69.0 pts
1 year-62.4%+12.0%−74.4 pts
3 years-9.9%+78.2%−88.1 pts-3.4%+21.2%
5 years-94.0%+73.2%−167.3 pts-43.1%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M SPRO shares were sold short on Oct 30, 2026, down 6.4% from the previous report, or 1.79% of the shares available to trade. At recent volumes it would take 2.2 days to buy them back. Over the last 20 sessions, 37.9% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026787,025-6.4%353,0932.2
Oct 15, 2026840,529+5.8%558,4711.5
Sep 30, 2026794,509-18.6%1,144,0971.0
Sep 15, 2026976,488-19.3%319,4583.1
Aug 31, 20261,210,417-16.3%409,8133.0
Aug 14, 20261,445,879-4.5%760,5111.9
Jul 31, 20261,513,354-28.4%2,524,6911.0
Jul 15, 20262,113,935-26.2%1,649,6271.3
Jun 30, 20262,864,850+56.4%2,752,0491.0
Jun 15, 20261,831,713+7.3%813,3752.3
May 29, 20261,706,545+3.6%868,8682.0
May 15, 20261,647,297+39.6%630,4692.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?